ANGLE (LON:AGL) Trading Up 13.2% – Should You Buy?

Shares of ANGLE plc (LON:AGL) traded up 13.2% on Wednesday . The company traded as high as GBX 16.20 ($0.20) and last traded at GBX 15 ($0.19). 6,115,835 shares were traded during trading, an increase of 306% from the average session volume of 1,506,316 shares. The stock had previously closed at GBX 13.25 ($0.16).

Wall Street Analyst Weigh In

Separately, Berenberg Bank reaffirmed a “buy” rating and issued a GBX 40 ($0.50) target price on shares of ANGLE in a report on Wednesday.

ANGLE Trading Up 6.0 %

The stock has a market cap of £49.59 million, a price-to-earnings ratio of -219.64 and a beta of 0.22. The business’s 50 day moving average is GBX 11.03 and its 200 day moving average is GBX 11.17. The company has a debt-to-equity ratio of 17.22, a current ratio of 5.19 and a quick ratio of 6.18.

About ANGLE

ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in Europe, North America, and the United Kingdom. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD.